Navitor Pharma

Navitor Pharma

Navitor Pharma

Novel Therapeutics Targeting the Central Regulator of Nutrient Signaling
Raised
$56.5M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
$33,000,000
Venture capital (Series B) - 2015
Atlas Venture Polaris Partners SR One +4
Team Size
1–10
Employees
$33,000,000 Venture capital (Series B)
businesswire

Navitor Pharmaceuticals Announces $33 Million Series B Financing